CARLOMAGNO, Chiara
CARLOMAGNO, Chiara
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
Bevacizumab as 4th line treatment in metastatic colorectal cancer
2009 L., Cannella; Carlomagno, Chiara; DE STEFANO, Alfonso; S., Alfieri; M., Colantuoni; Ca, Cella; DE PLACIDO, Sabino
Surgery in lung cancer metastasis
2009 Carlomagno, Chiara; Ca, Cella; DE STEFANO, Alfonso; L., Cannella; S., Alfieri; M., Colantuoni; DE PLACIDO, Sabino
Cancro del colon-retto
2011 Carlomagno, Chiara; DE PLACIDO, Sabino
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
2007 T., Suter; M., Procter; DJ Van, Veldhuisen; M., Muscholl; J., Bergh; Carlomagno, Chiara; T., Perren; R., Passalacqua; C., Bighin; J., Klijn; Ft, Ageev; E., Hiltre; J., Groetez; H., Iwata; M., Knap; M., Gnant; S., Muehlbauer; A., Spence; Rd, Gelber; MJ Piccart, Gebhart
Raltitrexed versus standard leucovorin-modulated 5Fluorouracil: results form the randomized phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1).
2008 Popov, I; Carrato, A; Sobrero, A; Vincent, M; Kerr, D; Labianca, R; Bianco, Ar; El Serafi, M; Bedenne, L; Paillot, B; Mini, E; Sanches, E; Welch, J; Colette, L; Praet, M; Wils, J; Carlomagno, Chiara
Cancro del colon-retto
2007 Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar
Cancro del colon-retto
2003 Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar
Skin lesions: unusual presentation of gastric cancer
2009 Alfieri, S; Carlomagno, Chiara; Colantuoni, M; De Stefano, A; Cannella, L; Cella, Ca; DE PLACIDO, Sabino
Naoadjuvant chemoradiation therapy with capecitabine (CAP) and oxaliplatin (OX) in rectal cancer: final results of a phase II study
2008 Carlomagno, Chiara; D'Armiento, FRANCESCO PAOLO; Farella, A; Cannella, L; De Stefano, A; Colantuoni, M; Alfieri, S; Marra, M; Totaro, G; Pepe, S.
FOLFOXIRI plus bevacizumab (bev) versus FOLFIRI plus bev as first-line treatment of metastatic coloectal cancer (MCRC): results of the phase III tandomized TRIBE trial
2013 Luopakis, F; Cremolini, C; Masi, G; Lonardi, S; Zagonel, V; Trenta, P; Tomasello, G; Ronzoni, M; Ciuffreda, L; Zaniboni, A; Tonini, G; Buonadonna, A; Valsuani, C; Chiara, S; Carlomagno, Chiara; Boni, C; Marcucci, L; Boni, L; Falcone, A.
Guillain Barrè syndrome associated with gastric cancer: paraneoplastic syndrome or immunological disorder?
2010 Colantuoni, Maria; Matano, E; Alfieri, Salvatore; DE PLACIDO, Sabino; Carlomagno, Chiara
Cancro del colon-retto
1999 Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar
Correlation between bevacizumab-related hypertension and response in mCRC patients
2010 DE STEFANO, Alfonso; L., Cannella; Carlomagno, Chiara; A., Crispo; Bianco, Roberto; Marciano, Roberta; Pepe, Stefano; DE PLACIDO, Sabino
Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models
2012 Bianco, Roberto; R., Rosa; L., Nappi; Formisano, Luigi; V., Damiano; C., D'Amato; A. P., de Maio; Marciano, Roberta; Malapelle, Umberto; Troncone, Giancarlo; Carlomagno, Chiara; DE STEFANO, Alfonso; G., Tortora; DE PLACIDO, Sabino
Manuale di Oncologia Clinica
1996 Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo
Altri tumori gastrointestinali
2011 Tortora, Giampaolo; Palmieri, Giovannella; Carlomagno, Chiara
Il punto sull’Irinotecan: presente e futuro
2001 Carlomagno, Chiara
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
2010 Correa, C; Mcgale, P; Taylor, C; Wang, Y; Clarke, M; Davies, C; Peto, R; Bijker, N; Solin, L; Darby, S; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; Carlomagno, Chiara; DE PLACIDO, Sabino
Neoadjuvant chemoradiation therapy and pedictive factors of response to Capecitabine (CAP) and Oxaliplatin (OX) in rectal cancer patients: a phase II study
2008 De Stefano, A; Cannella, L; Carlomagno, Chiara; D'Armiento, FRANCESCO PAOLO; Farella, Antonio; Crispo, A; DE PLACIDO, Sabino; Pepe, S.
HER2 as predictive marker of resistance to endocrine treatment for advanced bresat cancer: a metanalysis of published studies
2002 DE LAURENTIIS, Michelino; Arpino, Grazia; E., Massarelli; A., Ruggiero; Carlomagno, Chiara; G., Tortora; F., Ciardiello; Ar, Bianco
Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
---|---|---|---|---|
Bevacizumab as 4th line treatment in metastatic colorectal cancer | 1.5 Abstract in rivista | 2009 | L., Cannella; Carlomagno, Chiara; DE STEFANO, Alfonso; S., Alfieri; M., Colantuoni; Ca, Cella; DE PLACIDO, Sabino | |
Surgery in lung cancer metastasis | 1.5 Abstract in rivista | 2009 | Carlomagno, Chiara; Ca, Cella; DE STEFANO, Alfonso; L., Cannella; S., Alfieri; M., Colantuoni; DE PLACIDO, Sabino | |
Cancro del colon-retto | 2.1 Contributo in volume (Capitolo o Saggio) | 2011 | Carlomagno, Chiara; DE PLACIDO, Sabino | |
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial | 1.5 Abstract in rivista | 2007 | T., Suter; M., Procter; DJ Van, Veldhuisen; M., Muscholl; J., Bergh; Carlomagno, Chiara; T., Perren; R., Passalacqua; C., Bighin; J., Klijn; Ft, Ageev; E., Hiltre; J., Groetez; H., Iwata; M., Knap; M., Gnant; S., Muehlbauer; A., Spence; Rd, Gelber; MJ Piccart, Gebhart | |
Raltitrexed versus standard leucovorin-modulated 5Fluorouracil: results form the randomized phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1). | 1.1 Articolo in rivista | 2008 | Popov, I; Carrato, A; Sobrero, A; Vincent, M; Kerr, D; Labianca, R; Bianco, Ar; El Serafi, M; Bedenne, L; Paillot, B; Mini, E; Sanches, E; Welch, J; Colette, L; Praet, M; Wils, J; Carlomagno, Chiara | |
Cancro del colon-retto | 2.1 Contributo in volume (Capitolo o Saggio) | 2007 | Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar | |
Cancro del colon-retto | 2.1 Contributo in volume (Capitolo o Saggio) | 2003 | Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar | |
Skin lesions: unusual presentation of gastric cancer | 1.5 Abstract in rivista | 2009 | Alfieri, S; Carlomagno, Chiara; Colantuoni, M; De Stefano, A; Cannella, L; Cella, Ca; DE PLACIDO, Sabino | |
Naoadjuvant chemoradiation therapy with capecitabine (CAP) and oxaliplatin (OX) in rectal cancer: final results of a phase II study | 1.5 Abstract in rivista | 2008 | Carlomagno, Chiara; D'Armiento, FRANCESCO PAOLO; Farella, A; Cannella, L; De Stefano, A; Colantuoni, M; Alfieri, S; Marra, M; Totaro, G; Pepe, S. | |
FOLFOXIRI plus bevacizumab (bev) versus FOLFIRI plus bev as first-line treatment of metastatic coloectal cancer (MCRC): results of the phase III tandomized TRIBE trial | 1.5 Abstract in rivista | 2013 | Luopakis, F; Cremolini, C; Masi, G; Lonardi, S; Zagonel, V; Trenta, P; Tomasello, G; Ronzoni, M; Ciuffreda, L; Zaniboni, A; Tonini, G; Buonadonna, A; Valsuani, C; Chiara, S; Carlomagno, Chiara; Boni, C; Marcucci, L; Boni, L; Falcone, A. | |
Guillain Barrè syndrome associated with gastric cancer: paraneoplastic syndrome or immunological disorder? | 1.1 Articolo in rivista | 2010 | Colantuoni, Maria; Matano, E; Alfieri, Salvatore; DE PLACIDO, Sabino; Carlomagno, Chiara | |
Cancro del colon-retto | 2.1 Contributo in volume (Capitolo o Saggio) | 1999 | Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar | |
Correlation between bevacizumab-related hypertension and response in mCRC patients | 1.5 Abstract in rivista | 2010 | DE STEFANO, Alfonso; L., Cannella; Carlomagno, Chiara; A., Crispo; Bianco, Roberto; Marciano, Roberta; Pepe, Stefano; DE PLACIDO, Sabino | |
Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models | 1.5 Abstract in rivista | 2012 | Bianco, Roberto; R., Rosa; L., Nappi; Formisano, Luigi; V., Damiano; C., D'Amato; A. P., de Maio; Marciano, Roberta; Malapelle, Umberto; Troncone, Giancarlo; Carlomagno, Chiara; DE STEFANO, Alfonso; G., Tortora; DE PLACIDO, Sabino | |
Manuale di Oncologia Clinica | 2.1 Contributo in volume (Capitolo o Saggio) | 1996 | Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo | |
Altri tumori gastrointestinali | 2.1 Contributo in volume (Capitolo o Saggio) | 2011 | Tortora, Giampaolo; Palmieri, Giovannella; Carlomagno, Chiara | |
Il punto sull’Irinotecan: presente e futuro | 1.1 Articolo in rivista | 2001 | Carlomagno, Chiara | |
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. | 1.1 Articolo in rivista | 2010 | Correa, C; Mcgale, P; Taylor, C; Wang, Y; Clarke, M; Davies, C; Peto, R; Bijker, N; Solin, L; Darby, S; Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; Carlomagno, Chiara; DE PLACIDO, Sabino | |
Neoadjuvant chemoradiation therapy and pedictive factors of response to Capecitabine (CAP) and Oxaliplatin (OX) in rectal cancer patients: a phase II study | 1.5 Abstract in rivista | 2008 | De Stefano, A; Cannella, L; Carlomagno, Chiara; D'Armiento, FRANCESCO PAOLO; Farella, Antonio; Crispo, A; DE PLACIDO, Sabino; Pepe, S. | |
HER2 as predictive marker of resistance to endocrine treatment for advanced bresat cancer: a metanalysis of published studies | 1.5 Abstract in rivista | 2002 | DE LAURENTIIS, Michelino; Arpino, Grazia; E., Massarelli; A., Ruggiero; Carlomagno, Chiara; G., Tortora; F., Ciardiello; Ar, Bianco |